John Schoen, Senior Clinical Manager of Drug Information, at Vizient, shares his insights on the history and current state of pneumococcal vaccines within the practitioner community. He also discusses the complexity of ACIP recommendations after the recent addition of two newer vaccines, PCV 20 and PCV 15, and what the future holds for the vaccines.

Guest speaker:

Moderator:

Show Notes:

[00:51-1:51] John’s background

[01:52-4:22] Pneumococcal vaccines history and current

[04:23-7:30] Significance of vaccines

[07:31-9:33] What’s new with Pneumococcal vaccines

[09:34-12:00] How expanded serotype coverage changes things

[12:01-15:37] Efficacy data points from recent studies

[15:38-16:26] Safety concerns from trials

[16:27-18:51] Current ACIP recommendations

[18:52-23:10] How to deal with the different combinations of vaccines

[23:11-24:37] Safety implications of vaccine combinations

[24:38-25:43] How frontline staff positions itself for appropriate support

[25:44-27:50] What to expect for the future of pneumococcal immunizations

Links | Resources:

Side-by-side comparison for the pneumococcal vaccines

Public access link: Click Here

Member only (comprehensive) link: Click Here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed